Dermata Therapeutics shares rise 18.60% after-hours as positive clinical trial developments boost optimism.

viernes, 20 de marzo de 2026, 4:08 pm ET1 min de lectura
DRMA--
Dermata Therapeutics Inc. surged 18.60% in after-hours trading amid positive clinical trial developments and a strategic expansion of its skincare division. The stock's upward momentum aligns.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios